Companies Johnson & Johnson FollowApril 10 (Reuters) - Johnson & Johnson's renewed effort to resolve talc lawsuits through an $8.9 billion bankruptcy settlement must be dismissed as a "fraudulent scheme" that defies a court order rejecting the company's previous attempt to settle the litigation, according to a court filing from lawyers representing cancer victims. Circuit Court of Appeals that it was not in sufficient "financial distress" to qualify for bankruptcy. J&J maintains that its talc products are safe and do not cause cancer. J&J did not provide an estimate of the total number of talc claims it faces when asked. That's especially true for J&J talc cases, because LTL's first bankruptcy stopped new lawsuits from being filed after October 2021, he said.

---